TREATMENT OF DONOR BONE-MARROW WITH MONOCLONAL ANTI-T-CELL ANTIBODY AND COMPLEMENT FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TRIAL

被引:324
作者
MITSUYASU, RT
CHAMPLIN, RE
GALE, RP
HO, WG
LENARSKY, C
WINSTON, D
SELCH, M
ELASHOFF, R
GIORGI, JV
WELLS, J
TERASAKI, P
BILLING, R
FEIG, S
机构
[1] UNIV CALIF LOS ANGELES, SCH MED, TRANSPLANTAT BIOL PROGRAM, LOS ANGELES, CA 90024 USA
[2] UNIV CALIF LOS ANGELES, SCH MED, DEPT PEDIAT, LOS ANGELES, CA 90024 USA
[3] UNIV CALIF LOS ANGELES, SCH MED, DEPT SURG, LOS ANGELES, CA 90024 USA
[4] UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOMATH, LOS ANGELES, CA 90024 USA
[5] UNIV CALIF LOS ANGELES, SCH MED, DEPT RADIAT ONCOL, LOS ANGELES, CA 90024 USA
[6] UNIV CALIF LOS ANGELES, SCH MED, DEPT MICROBIOL & IMMUNOL, LOS ANGELES, CA 90024 USA
[7] UNIV CALIF LOS ANGELES, CTR HLTH SCI, JONSSON COMPREHENS CANC CTR, LOS ANGELES, CA 90024 USA
关键词
D O I
10.7326/0003-4819-105-1-20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:20 / 26
页数:7
相关论文
共 63 条
  • [1] BORTIN MM, 1985, EXP HEMATOL, V13, P406
  • [2] BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P51
  • [3] BUTTURINI A, 1986, J BIOCH SD, V10, P224
  • [4] CHAMPLIN R, 1985, SEMIN ONCOL, V12, P190
  • [5] CHAMPLIN RE, 1984, CANCER TREAT REP, V68, P145
  • [6] CYCLOSPORINE AS PROPHYLAXIS FOR GRAFT-VERSUS-HOST DISEASE - A RANDOMIZED STUDY IN PATIENTS UNDERGOING MARROW TRANSPLANTATION FOR ACUTE NONLYMPHOBLASTIC LEUKEMIA
    DEEG, HJ
    STORB, R
    THOMAS, ED
    FLOURNOY, N
    KENNEDY, MS
    BANAJI, M
    APPELBAUM, FR
    BENSINGER, WI
    BUCKNER, CD
    CLIFT, RA
    DONEY, K
    FEFER, A
    MCGUFFIN, R
    SANDERS, JE
    SINGER, J
    STEWART, P
    SULLIVAN, KM
    WITHERSPOON, RP
    [J]. BLOOD, 1985, 65 (06) : 1325 - 1334
  • [7] SELECTIVE ELIMINATION OF IMMUNOLOGICALLY COMPETENT CELLS FROM BONE MARROW AND LYMPHATIC CELL MIXTURES .2. MOUSE SPLEEN CELL FRACTIONATION ON A DISCONTINUOUS ALBUMIN GRADIENT
    DICKE, KA
    VANHOOFT, JI
    VANBEKKU.DW
    [J]. TRANSPLANTATION, 1968, 6 (04) : 562 - &
  • [8] FAILURE OF EARLY ADMINISTRATION OF ANTI-THYMOCYTE GLOBULIN TO LESSEN GRAFT VERSUS HOST-DISEASE IN HUMAN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS
    DONEY, KC
    WEIDEN, PL
    STORB, R
    THOMAS, ED
    [J]. TRANSPLANTATION, 1981, 31 (02) : 141 - 143
  • [9] FILIPOVICH AH, 1984, LANCET, V1, P469
  • [10] FILIPOVICH AH, 1982, LANCET, V1, P1266